Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Thomas J. Walsh(Cornell University), Thomas F. Patterson(National Institute of Allergy and Infectious Diseases), Dimitrios P. Kontoyiannis(The University of Texas MD Anderson Cancer Center), Raoul Herbrecht(Institut de Cancérologie Strasbourg), William J. Steinbach(Duke Medical Center), Brahm H. Segal(Roswell Park Comprehensive Cancer Center), Kieren A. Marr(Freedom to Live), David W. Denning(Manchester Academic Health Science Centre), Elias Anaissie(Clinical Trial and Consulting), Jo‐Anne van Burik(University of Minnesota System), John R. Wingard(University of Florida Health), Vicki A. Morrison(University of Minnesota), David A. Stevens(Stanford University)
Cited by 2,702
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k